Erschienen in:
03.04.2017 | Erratum
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials
verfasst von:
M. V. Dieci, A. Frassoldati, D. Generali, G. Bisagni, F. Piacentini, L. Cavanna, K. Cagossi, F. Puglisi, A. Michelotti, R. Berardi, G. Banna, A. Goubar, G. Ficarra, G. Griguolo, Pierfranco Conte, V. Guarneri
Erschienen in:
Breast Cancer Research and Treatment
|
Ausgabe 3/2017
Einloggen, um Zugang zu erhalten
Excerpt
In the original publication of the article, the eighth and ninth co-author’s affiliations were published incorrectly. The correct affiliations of the co-authors are given in this erratum. …